ASHG recently submitted a response to the NOT-OD-22-029 Request for Information (RFI) from the National Institutes of Health (NIH) pertaining to its Genomic Data Sharing Policy (GDS policy). The GDS policy regulates the expectations and procedures for researchers who generate genomic data as part of their NIH-funded research, as well as for researchers who wish to gain access... Read More
Members of the American Society of Human Genetics (ASHG) strive to further understanding of the human genome for the betterment of science, health and society. As a community of genetics researchers, ASHG is deeply concerned by the passage and implementation of Texas law S.B. 8 and the potential passage of similar bills nationwide, which will... Read More
ASHG supports policies that promote genetic and genomic data sharing to advance research and health care with strong protections in place for genetic information. The Society is concerned that a provision in the Senate-passed U.S. Innovation and Competition Act (USICA, S.1260), that requires NIH to consider national security risks in the conduct of human genomic... Read More
A draft bill introduced in May 2019 sought to reform Section 101 of the U.S. Patent Act. If passed, the legislation would allow for the patenting of genes by effectively overturning the 2013 Association for Molecular Pathology (AMP) vs. Myriad Supreme Court decision. Related: Joint Letter from ASHG and ACMG Leadership to Bill Sponsors (July... Read More
Genetics research is providing remarkable insights into the human genome and how this knowledge can be translated into healthcare advances. This scientific progress relies on continued public investment in biomedical research. ASHG supports the robust, predictable, sustainable federal funding of research to fuel scientific advances. Related: Written Testimony to Senate Appropriations LHHS Subcommittee (May 2023)... Read More
ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy